https://ana.ir/en/news/11205/nanomicellar-capsule-developed-to-support-liver-health2026-09-14T18:16:43+03:30Nanomicellar capsule developed to support liver healthana.pressenhttps://ana.ir/media/f252cf5cZTp3ZWJwfGY6MTE4OTY3Mi5qcGd8ZnVpOjgwODUzfGw6ZW58djox.webpNanomicellar capsule developed to support liver health(Tehran Ana)- An Iranian knowledge-based company has developed and launched an oral formulation containing nanomicellar silymarin to help prevent and manage liver diseases and damage.https://ana.ir/en/news/11204/study-reveals-molecular-mechanism-behind-heparin-induced-thrombocytopenia2026-09-14T17:33:33+03:30Study reveals molecular mechanism behind heparin-induced thrombocytopeniaana.pressenhttps://ana.ir/media/4669163fZTp3ZWJwfGY6MTE4OTY1OS5qcGd8ZnVpOjgwODUyfGw6ZW58djox.webpStudy reveals molecular mechanism behind heparin-induced thrombocytopenia(Tehran Ana)- Researchers at McMaster University have identified a structural mechanism in platelet factor 4 (PF4) that may trigger the harmful immune response underlying heparin-induced thrombocytopenia (HIT).